|Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment|
G Bertolini, L Roz, P Perego, M Tortoreto, E Fontanella, L Gatti, G Pratesi, ...
Proceedings of the National Academy of Sciences 106 (38), 16281-16286, 2009
|The FHIT gene at 3p14. 2 is abnormal in lung cancer|
G Sozzi, ML Veronese, M Negrini, R Baffa, MG Cotticelli, H Inoue, ...
Cell 85 (1), 17-26, 1996
|MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer|
M Boeri, C Verri, D Conte, L Roz, P Modena, F Facchinetti, E Calabr˛, ...
Proceedings of the National Academy of Sciences 108 (9), 3713-3718, 2011
|Quantification of free circulating DNA as a diagnostic marker in lung cancer|
G Sozzi, D Conte, ME Leon, R Cirincione, L Roz, C Ratcliffe, E Roz, ...
Journal of clinical oncology 21 (21), 3902-3908, 2003
|Deregulation of the platelet-derived growth factor β-chain gene via fusion with collagen gene COL1A1 in dermatof ibrosarcoma protuberans and giant-cell fibroblastoma|
MP Simon, F Pedeutour, N Sirvent, J Grosgeorge, F Minoletti, JM Coindre, ...
Nature genetics 15 (1), 95, 1997
|Replacement of Fhit in cancer cells suppresses tumorigenicity|
Z Siprashvili, G Sozzi, LD Barnes, P McCue, AK Robinson, V Eryomin, ...
Proceedings of the National Academy of Sciences 94 (25), 13771-13776, 1997
|Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients|
G Sozzi, D Conte, L Mariani, SL Vullo, L Roz, C Lombardo, MA Pierotti, ...
Cancer research 61 (12), 4675-4678, 2001
|Loss of FHIT function in lung cancer and preinvasive bronchial lesions|
G Sozzi, U Pastorino, L Moiraghi, E Tagliabue, F Pezzella, C Ghirelli, ...
Cancer research 58 (22), 5032-5037, 1998
|Immunocytochemical markers in stage I lung cancer: relevance to prognosis.|
U Pastorino, S Andreola, E Tagliabue, F Pezzella, M Incarbone, G Sozzi, ...
Journal of clinical oncology 15 (8), 2858-2865, 1997
|EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues|
MP Martelli, G Sozzi, L Hernandez, V Pettirossi, A Navarro, D Conte, ...
The American journal of pathology 174 (2), 661-670, 2009
|The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control|
L Sard, P Accornero, S Tornielli, D Delia, G Bunone, M Campiglio, ...
Proceedings of the National Academy of Sciences 96 (15), 8489-8492, 1999
|Deletions of 17p and p53 mutations in preneoplastic lesions of the lung|
G Sozzi, M Miozzo, R Donghi, S Pilotti, CT Cariani, U Pastorino, ...
Cancer research 52 (21), 6079-6082, 1992
|Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis.|
F Pezzella, U Pastorino, E Tagliabue, S Andreola, G Sozzi, G Gasparini, ...
The American journal of pathology 151 (5), 1417, 1997
|Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial|
U Pastorino, M Rossi, V Rosato, A Marchian˛, N Sverzellati, C Morosi, ...
European Journal of Cancer Prevention 21 (3), 308-315, 2012
|Role of FHIT in Human Cancer|
CM Croce, G Sozzi, K Huebner
Journal of Clinical Oncology 17 (5), 1618-1618, 1999
|Low frequency of alterations of the α (PPP2R1A) and β (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms|
GA Calin, MG Di Iasio, E Caprini, I Vorechovsky, PG Natali, G Sozzi, ...
Oncogene 19 (9), 1191, 2000
|Association between cigarette smoking and FHIT gene alterations in lung cancer|
G Sozzi, L Sard, L De Gregorio, A Marchetti, K Musso, F Buttitta, ...
Cancer Research 57 (11), 2121-2123, 1997
|Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC.|
MA Pierotti, M Santoro, RB Jenkins, G Sozzi, I Bongarzone, M Grieco, ...
Proceedings of the National Academy of Sciences 89 (5), 1616-1620, 1992
|SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas|
P Modena, E Lualdi, F Facchinetti, L Galli, MR Teixeira, S Pilotti, G Sozzi
Cancer research 65 (10), 4012-4019, 2005
|Tumor-initiating cells of HER2-positive carcinoma cell lines express the highest oncoprotein levels and are sensitive to trastuzumab|
A Magnifico, L Albano, S Campaner, D Delia, F Castiglioni, P Gasparini, ...
Clinical Cancer Research 15 (6), 2010-2021, 2009